GeneDx President files initial Form 3

GeneDx Holdings Corp. filed an initial insider ownership report for President Mark A. Gardner on a Form 3.

Accepted by SEC EDGAR 06/16/2026 - 04:10 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

GeneDx Holdings Corp. filed an initial insider ownership report for President Mark A. Gardner on a Form 3. The filing identifies Gardner as an officer of the company but does not list any specific transactions or derivative positions in the data provided.

Key Terms

Form 3, reportingPersons, transactionSummary

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [{"name": "GARDNER MARK A""

transactionSummary financial

""transactionSummary": {"buyCount": 0, "sellCount": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GeneDx (WGS) Form 3 filing for Mark A. Gardner show?

The Form 3 filing identifies Mark A. Gardner as President of GeneDx Holdings Corp. It serves as an initial statement of insider status but, in the data provided, shows no specific holdings or transactions.

Did Mark A. Gardner buy or sell GeneDx (WGS) shares in this Form 3?

No transactions are reported in this Form 3. The transaction summary fields show zero buys, zero sells, and no derivative exercises, indicating the filing is purely an initial ownership report in the provided data.

What role does Mark A. Gardner hold at GeneDx (WGS) in this filing?

Mark A. Gardner is listed as an officer with the title of President at GeneDx Holdings Corp. This confirms his executive status for insider reporting purposes under SEC rules in the Form 3 filing.

Are any derivative securities reported for Mark A. Gardner in the GeneDx Form 3?

No derivative securities are shown in the provided data. The derivativeSummary is empty and derivativeTransactionCount is zero, indicating no options, warrants, or similar instruments are listed in this Form 3 snapshot.

What is the purpose of this GeneDx (WGS) Form 3 for investors?

This Form 3 establishes Mark A. Gardner as an insider, specifically President of GeneDx Holdings Corp. It is an initial disclosure of insider status, with no reported trades or derivative positions in the data provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

GARDNER MARK A

(Last) (First) (Middle)

C/O GENEDX HOLDINGS CORP.

333 LUDLOW ST., NORTH TOWER, 6TH FLOOR

(Street)

STAMFORD CONNECTICUT 06902

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/15/2026

3. Issuer Name and Ticker or Trading Symbol
GeneDx Holdings Corp. [ WGS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Bridget Brown, Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)